Multidisciplinary Approach to Treating Advanced Endometrial Cancer-Recording

Video Transcription

Video Summary

The webinar titled "Multidisciplinary Approach to Treating Advanced Endometrial Cancer" was hosted by Flora Backus, a gynecologic oncologist and professor at The Ohio State University and James Cancer Center. The webinar was part of the IGCS Education Advances and Updates workgroup and was sponsored by ECI. The webinar aimed to provide education on current and future treatments for gynecologic oncology professionals to optimize patient care. The webinar discussed the approval of the combination treatment, Levatinib and Pembrolizumab, for patients with advanced endometrial cancer. Data from clinical trials were presented, showing improved outcomes in terms of progression-free survival, overall survival, objective response rates, and duration of response. The panelists also discussed the management of common side effects, including hypertension, hypothyroidism, diarrhea, and fatigue. They emphasized the importance of educating patients about potential side effects and providing supportive care measures. The panelists highlighted the need for multidisciplinary teamwork and close monitoring of patients to manage side effects effectively. They also mentioned upcoming educational materials for patients to further support their understanding of the treatment. The webinar concluded with the panelists encouraging clinicians to become familiar with managing the side effects of this combination treatment in order to provide the best care for patients with advanced endometrial cancer. The video recording of the webinar and additional resources are available on the IGCS Education 360 Learning Portal.

Keywords

Endometrial Cancer

Multidisciplinary Approach

Combination Treatment

Clinical Trials

Side Effects

Patient Care

Education

Supportive Care